Latest News in the pharma Industry

Market News

Mylan receives WHO Prequalification for generic Sovaldi

Mylan receives WHO Prequalification for generic Sovaldi

26 Jul 2017

First generic prequalification for sofosbuvir tablets.

Read more 
BMS's Orencia receives second EC approval in less than a year

BMS's Orencia receives second EC approval in less than a year

26 Jul 2017

New approval for treatment of active psoriatic arthritis (PsA).

Read more 
Vertex and Concert Pharmaceuticals complete asset purchase agreement for CTP-656

Vertex and Concert Pharmaceuticals complete asset purchase agreement for CTP-656

26 Jul 2017

Vertex now has worldwide development and commercialization rights to CTP-656 and other assets related to the treatment of cystic fibrosis.

Read more 
Artificial intelligence to discover drugs in a multi-year multimillion dollar deal

Artificial intelligence to discover drugs in a multi-year multimillion dollar deal

26 Jul 2017

AI thought to have massive potential to reduce the cost associated with the discovery of new drugs.

Read more 
New research highlights lack of confidence in serialization preparations

New research highlights lack of confidence in serialization preparations

25 Jul 2017

40% of industry professionals admit they are not clear about the global requirements for serialization.

Read more 
STA signs 5-year supply agreement with TESARO

STA signs 5-year supply agreement with TESARO

24 Jul 2017

STA will provide supplies of certain starting and intermediate materials for the recently launched Zejula.

Read more 
Merck launches Remicade biosimilar for all eligible indications, in the US

Merck launches Remicade biosimilar for all eligible indications, in the US

24 Jul 2017

The biosimilar's list price will represent a 35% discount to the current list price of Remicade.

Read more 
Lilly backs Nektar Therapeutics' novel immunological therapy

Lilly backs Nektar Therapeutics' novel immunological therapy

24 Jul 2017

NKTR-358 has the potential to treat a number of autoimmune and other chronic inflammatory conditions.

Read more 
GSK receives FDA approval for a new self-injectable formulation of Benlysta

GSK receives FDA approval for a new self-injectable formulation of Benlysta

23 Jul 2017

The approval marks the first subcutaneous self-injection treatment option for patients with systemic lupus erythematosus.

Read more 
Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility

Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility

23 Jul 2017

Expansion will triple capacity, add nearly 300 new jobs.

Read more 
Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging

Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging

23 Jul 2017

Collaborations result in development of Corning Valor Glass.

Read more 
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product

Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product

20 Jul 2017

GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry.

Read more